Literature DB >> 27159138

Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk.

Rutger A Middelburg1,2, Jannemieke C Carbaat-Ham1, Husna Hesam1, Max A A D Ragusi1, Jaap Jan Zwaginga1,3.   

Abstract

OBJECTIVES: To test whether, together with platelet count, platelet activity could be an important predictor of bleeding risk in immune thrombocytopenia (ITP) patients.
METHODS: Platelet activity was tested by flow cytometric measurement of agonist induced P-selectin expression and compared between 23 adult ITP patients and 22 healthy volunteers.
RESULTS: Platelet activity could be either increased or decreased in ITP patients, compared to healthy volunteers. In the lowest platelet count category, normal to low platelet activity was associated with the biggest increase in bleeding risk. Risk difference 80% (95% confidence interval: 45-115%) for <32 × 10(9) platelets/L. For higher platelet counts, there was no association of platelet activity with bleeding risk. DISCUSSION: Increased platelet activity was associated with decreased bleeding risk, but only in patients with low platelet counts.
CONCLUSION: Platelet activity can be a predictor of bleeding risk in ITP patients with low platelet counts.

Entities:  

Keywords:  Bleeding; Immune thrombocytopenia (ITP); Platelet function; Platelets

Mesh:

Year:  2016        PMID: 27159138     DOI: 10.1080/10245332.2016.1180097

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

Review 1.  Clinical updates in adult immune thrombocytopenia.

Authors:  Michele P Lambert; Terry B Gernsheimer
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

2.  Changing profile of platelet activity and turnover indices during treatment response of immune thrombocytopenia.

Authors:  Chewei Ou; Hung Chang; Yu-Shin Hung; Ming-Chung Kuo; Pei-Ling Li; Tung-Liang Lin
Journal:  Clin Exp Med       Date:  2022-02-08       Impact factor: 5.057

3.  Platelet dysfunction contributes to bleeding complications in patients with probable leptospirosis.

Authors:  Rahajeng N Tunjungputri; Muhammad Hussein Gasem; Willemijn van der Does; Pandu H Sasongko; Bambang Isbandrio; Rolf T Urbanus; Philip G de Groot; Andre van der Ven; Quirijn de Mast
Journal:  PLoS Negl Trop Dis       Date:  2017-09-21

Review 4.  Platelets in ITP: Victims in Charge of Their Own Fate?

Authors:  Vivianne S Nelson; Anne-Tess C Jolink; Sufia N Amini; Jaap Jan Zwaginga; Tanja Netelenbos; John W Semple; Leendert Porcelijn; Masja de Haas; Martin R Schipperus; Rick Kapur
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

Review 5.  Recent advances in understanding and management of acquired thrombocytopenia.

Authors:  Srikanth Nagalla; Ravindra Sarode
Journal:  F1000Res       Date:  2018-01-17

6.  Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.

Authors:  Adrian C Newland; Blanca Sánchez-González; László Rejtő; Miklos Egyed; Nataliya Romanyuk; Marie Godar; Katrien Verschueren; Domenica Gandini; Peter Ulrichts; Jon Beauchamp; Torsten Dreier; E Sally Ward; Marc Michel; Howard A Liebman; Hans de Haard; Nicolas Leupin; David J Kuter
Journal:  Am J Hematol       Date:  2019-12-10       Impact factor: 10.047

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.